Mongodb Inc vs Novo Nordisk A/S — how do they compare? Mongodb Inc trades at $435.14 (market cap $35.32B), while Novo Nordisk A/S trades at $45.8 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 5.9× Mongodb Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Mongodb Inc pays none. Which is the better fit depends on your goals.
| MDB | NVO | |
|---|---|---|
Market Cap | $35.32B | $207.85B |
Sector | Technology | Health |
52-Week High | $440.25 | $63.98 |
52-Week Low | $204.37 | $35.29 |
Enterprise Value | $32.93B | $222.55B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →